APA (7th ed.) Citation

Schenk, T., Fabisch, C., Ernst, T., Ernst, P., Saußele, S., Žáčková, D., . . . Hochhaus, A. (2026). Ponatinib for CML patients in routine clinical practice: The PONDEROSA study. Annals of hematology, 105, . https://doi.org/10.1007/s00277-026-06788-6

Chicago Style (17th ed.) Citation

Schenk, Thomas, Christian Fabisch, Thomas Ernst, Philipp Ernst, Susanne Saußele, Daniela Žáčková, Jiří Mayer, Hana Klamová, and Andreas Hochhaus. "Ponatinib for CML Patients in Routine Clinical Practice: The PONDEROSA Study." Annals of Hematology 105 (2026). https://doi.org/10.1007/s00277-026-06788-6.

MLA (9th ed.) Citation

Schenk, Thomas, et al. "Ponatinib for CML Patients in Routine Clinical Practice: The PONDEROSA Study." Annals of Hematology, vol. 105, 2026, https://doi.org/10.1007/s00277-026-06788-6.